Correlation Between Akebia Therapeutics and CARSALESCOM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akebia Therapeutics and CARSALESCOM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akebia Therapeutics and CARSALESCOM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akebia Therapeutics and CARSALESCOM, you can compare the effects of market volatilities on Akebia Therapeutics and CARSALESCOM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akebia Therapeutics with a short position of CARSALESCOM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akebia Therapeutics and CARSALESCOM.

Diversification Opportunities for Akebia Therapeutics and CARSALESCOM

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Akebia and CARSALESCOM is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Akebia Therapeutics and CARSALESCOM in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CARSALESCOM and Akebia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akebia Therapeutics are associated (or correlated) with CARSALESCOM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CARSALESCOM has no effect on the direction of Akebia Therapeutics i.e., Akebia Therapeutics and CARSALESCOM go up and down completely randomly.

Pair Corralation between Akebia Therapeutics and CARSALESCOM

Assuming the 90 days trading horizon Akebia Therapeutics is expected to generate 2.94 times more return on investment than CARSALESCOM. However, Akebia Therapeutics is 2.94 times more volatile than CARSALESCOM. It trades about 0.07 of its potential returns per unit of risk. CARSALESCOM is currently generating about 0.07 per unit of risk. If you would invest  105.00  in Akebia Therapeutics on September 12, 2024 and sell it today you would earn a total of  77.00  from holding Akebia Therapeutics or generate 73.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Akebia Therapeutics  vs.  CARSALESCOM

 Performance 
       Timeline  
Akebia Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Akebia Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Akebia Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
CARSALESCOM 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CARSALESCOM are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, CARSALESCOM may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Akebia Therapeutics and CARSALESCOM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akebia Therapeutics and CARSALESCOM

The main advantage of trading using opposite Akebia Therapeutics and CARSALESCOM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akebia Therapeutics position performs unexpectedly, CARSALESCOM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CARSALESCOM will offset losses from the drop in CARSALESCOM's long position.
The idea behind Akebia Therapeutics and CARSALESCOM pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments